United States Daily Briefing

INTC -8.5% and AMD -7.3% confirm that the semiconductor complex is digesting the AI-trade premium at current levels — not a thesis break, but a significant de-risking event for the sector's richest valuations. JPM +3.7% and Visa +2.9% were the obvious rotation recipients, with money moving from high-multiple growth into dividend-supported financials. Watch whether the semis find support near current levels or extend lower toward the next technical zone, which will set the risk-appetite tone for the rest of the week.

Olin and Huntsman announced a merger that creates a major specialty chemicals combination, per Seeking Alpha's analysis of the opportunity. The deal creates synergy optionality in a sector that has lagged the broader market on weak demand signals, and the combined entity could command a valuation re-rating once the integration thesis is stress-tested. Chemicals M&A typically marks a sector inflection point — watch whether peer BASF or LyondellBasell experience multiple re-ratings in sympathy.

CNBC flagged two notable institutional signals: Eli Lilly opened its checkbook again with a new acquisition move, extending its post-Mounjaro capital deployment pace into additional pipeline assets. Separately, a Broadcom insider buy in a session where tech broadly sold off is a contrarian signal worth noting — insiders rarely buy into sector-wide weakness without conviction. With Lilly's pharma M&A and Broadcom's insider confidence both positive signals, the pharmaceutical and semiconductor equipment sub-sectors carry divergent reads heading into the next week.